| Dr-Dre vs King | 99–89 | 52.66% |
| Dr-Dre vs Jin | 68–71 | 48.92% |
| Dr-Dre vs Kazuya | 64–75 | 46.04% |
| Dr-Dre vs Reina | 73–66 | 52.52% |
| Dr-Dre vs Steve | 64–54 | 54.24% |
| Dr-Dre vs Bryan | 51–65 | 43.97% |
| Dr-Dre vs Hwoarang | 50–62 | 44.64% |
| Dr-Dre vs Law | 61–42 | 59.22% |
| Dr-Dre vs Eddy | 32–62 | 34.04% |
| Dr-Dre vs Jun | 39–48 | 44.83% |
| Dr-Dre vs Azucena | 31–50 | 38.27% |
| Dr-Dre vs Heihachi | 38–43 | 46.91% |
| Dr-Dre vs Dragunov | 31–39 | 44.29% |
| Dr-Dre vs Paul | 31–36 | 46.27% |
| Dr-Dre vs Lars | 25–41 | 37.88% |
| Dr-Dre vs Nina | 27–39 | 40.91% |
| Dr-Dre vs Lee | 29–34 | 46.03% |
| Dr-Dre vs Lili | 29–33 | 46.77% |
| Dr-Dre vs Yoshimitsu | 26–35 | 42.62% |
| Dr-Dre vs Asuka | 27–31 | 46.55% |
| Dr-Dre vs Devil Jin | 21–36 | 36.84% |
| Dr-Dre vs Feng | 17–30 | 36.17% |
| Dr-Dre vs Leo | 16–31 | 34.04% |
| Dr-Dre vs Xiaoyu | 24–19 | 55.81% |
| Dr-Dre vs Victor | 23–20 | 53.49% |
| Dr-Dre vs Alisa | 20–22 | 47.62% |
| Dr-Dre vs Leroy | 23–17 | 57.50% |
| Dr-Dre vs Shaheen | 21–18 | 53.85% |
| Dr-Dre vs Jack-8 | 13–18 | 41.94% |
| Dr-Dre vs Raven | 14–15 | 48.28% |
| Dr-Dre vs Lidia | 12–14 | 46.15% |
| Dr-Dre vs Claudio | 11–11 | 50.00% |
| Dr-Dre vs Kuma | 8–12 | 40.00% |
| Dr-Dre vs Zafina | 10–9 | 52.63% |
| Dr-Dre vs Clive | 1–4 | 20.00% |
| Dr-Dre vs Panda | 0–4 | 0.00% |
| Dr-Dre vs Anna | 0–4 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.